mrna-4157,pembrolizumab
merck,moderna
['mrna-4157', 'ct224', 'cross tumor', 'melanoma', 'pembro']
#aacr23 | section 47 | tuesday
ct224 - mrna-4157, a personalized cancer vaccine, in combination with pembrolizumab, demonstrates trend for improved recurrence free survival compared to pembrolizumab alone in adjuvant melanoma patients across tumor mutational burden subgroups
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.